Tag: General

WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has published its international patent application (Publication No. WO 2025/129197) titled, "Systems and Methods for Predicting Immunologically Active Peptides with Machine Learning Models."

Transaction in Own Shares

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

Strong top-line gains, reduced expenditures, and improved gross margins result in milestone quarter 

Golden Ocean Group Limited (NASDAQ: GOGL & Euronext Oslo Børs: GOGL) announces that a Special General Meeting will be held on August 19, 2025. A copy of the Notice of the Special General Meeting and associated information can be found enclosed and on our website at www.goldenocean.bm.
 

Company Announcement number 60/2025

Results of the Stellantis 2025 Extraordinary General Meeting of Shareholders

18 July 2025 - Reference is made to the stock exchange announcement published by Prosafe SE ("Prosafe" or the "Company") on 24 April 2025 where it was announced that Prosafe had agreed the terms of a recapitalization (the "Recapitalization") which, inter alia, includes a recapitalization of USD 193 million into 321,635,718 new shares in the Company (the "New Shares") and an offering of up to 17,868,651 warrants to shareholders in the Company as of 16 May 2025 as registered in the Euronext Securities Oslo (VPS) on the record date 20 May 2025 (the "Warrants"), subject to final approval being obtained by all lenders.